Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort

1. Alonso, S.
2. Riveiro-Barciela, M.
3. Fernandez, I.
4. Rincón, D.
5. Real, Y.
6. Llerena, S.
7. Gea, F.
8. Olveira, A.
9. Fernandez-Carrillo, C.
10. Polo, B.
11. Carrión, J.A.
12. Gómez, A.
13. Devesa, M.J.
14. Baliellas, C.
15. Castro, Á.
16. Ampuero, J.
17. Granados, R.
18. Pascasio, J.M.
19. Rubín, A.
20. Salmeron, J.
21. Badia, E.
22. Planas, J.M.M.
23. Lens, S.
24. Turnes, J.
25. Montero, J.L.
26. Buti, M.
27. Esteban, R.
28. Fernández-Rodríguez, C.M.
29. Show all authors +